re-evaluation 第1页

“Re-evaluation upon suspected event” is an approach for post-marketing clinical study： lessons from adverse drug events related to Bupleuri Radix preparations Review and reflection on re-evaluation system of Chinese patent medicine Design process and key points of clinical effectiveness re-evaluation on postmarketing herbs Systematic report on re-evaluating parenterally administered salvianolate Systematic report on re-evaluating Kudiezi injection Thinking about re-evaluation on symptoms of postmarketing Xuezhikang Capsula treating lipid abnormality Discussion on development of four diagnostic information scale for clinical re-evaluation of postmarketing herbs Skin test: guide of post-marketed re-evaluation of clinical safety in traditional Chinese medicine injection Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine Survey on Xiaoke pill treating diabetes mellitus in small cities‘ Chinese medicine hospital for post-marketing surveillance Post-marketing clinical study of traditional Chinese medicine——lessons learned from comprehensive evaluation of Fufang Zaoren capsule Clinical safety re-evaluation of post-marketing Chinese materia medica on syndrome Specificity of traditional Chinese medicine’s clinical re-evaluation Clinical re-evaluation of effects of different treatments to prevent from phlebitis induced by Chansu injection Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world Thought on several problems of post-marketing herbs clinical evaluation in special populations Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang Application of regular expression in extracting key information from Chinese medicine literatures about re-evaluation of post-marketing surveillance Postmarketing herbs clinical evaluation should concernabout re-evaluating symptoms Thought on several problems of clinical revaluationofpost-marketing herb research